Nucleon-nucleon momentum correlation function for light nuclei

Nucleon-nucleon momentum correlation function have been presented for nuclear reactions with neutron-rich or proton-rich projectiles using a nuclear transport theory, namely Isospin-Dependent Quantum Molecular Dynamics model. The relationship between the binding energy of projectiles and the strength of proton-neutron correlation function at small relative momentum has been explored, while proton-proton correlation function shows its sensitivity to the proton density distribution. Those results show that nucleon-nucleon correlation function is useful to reflect some features of the neutron- or proton-halo nuclei and therefore provide a potential tool for the studies of radioactive beam physics.Comment: Talk given at the 18th International IUPAP Conference on Few-Body Problems in Physics (FB18), Santos, Brasil, August 21-26, 2006. To appear in Nucl. Phys.

On the Convergence of Ritz Pairs and Refined Ritz Vectors for Quadratic Eigenvalue Problems

For a given subspace, the Rayleigh-Ritz method projects the large quadratic eigenvalue problem (QEP) onto it and produces a small sized dense QEP. Similar to the Rayleigh-Ritz method for the linear eigenvalue problem, the Rayleigh-Ritz method defines the Ritz values and the Ritz vectors of the QEP with respect to the projection subspace. We analyze the convergence of the method when the angle between the subspace and the desired eigenvector converges to zero. We prove that there is a Ritz value that converges to the desired eigenvalue unconditionally but the Ritz vector converges conditionally and may fail to converge. To remedy the drawback of possible non-convergence of the Ritz vector, we propose a refined Ritz vector that is mathematically different from the Ritz vector and is proved to converge unconditionally. We construct examples to illustrate our theory.Comment: 20 page

Scaling of Anisotropic Flow and Momentum-Space Densities for Light Particles in Intermediate Energy Heavy Ion Collisions

Anisotropic flows ($v_2$ and $v_4$) of light nuclear clusters are studied by Isospin-Dependent Quantum Molecular Dynamics model for the system of $^{86}$Kr + $^{124}$Sn at intermediate energy and large impact parameters. Number-of-nucleon scaling of the elliptic flow ($v_2$) are demonstrated for the light fragments up to $A$ = 4, and the ratio of $v_4/v_2^2$ shows a constant value of 1/2. In addition, the momentum-space densities of different clusters are also surveyed as functions of transverse momentum, in-plane transverse momentum and azimuth angle relative to the reaction plane. The results can be essentially described by momentum-space power law. All the above phenomena indicate that there exists a number-of-nucleon scaling for both anisotropic flow and momentum-space densities for light clusters, which can be understood by the coalescence mechanism in nucleonic degree of freedom for the cluster formation.Comment: 8 pages, 3 figures; to be published in Physics Letters

Scaling of anisotropy flows in intermediate energy heavy ion collisions

Anisotropic flows ($v_1$, $v_2$ and $v_4$) of light nuclear clusters are studied by a nucleonic transport model in intermediate energy heavy ion collisions. The number-of-nucleon scalings of the directed flow ($v_1$) and elliptic flow ($v_2$) are demonstrated for light nuclear clusters. Moreover, the ratios of $v_4/v_2^2$ of nuclear clusters show a constant value of 1/2 regardless of the transverse momentum. The above phenomena can be understood by the coalescence mechanism in nucleonic level and are worthy to be explored in experiments.Comment: Invited talk at "IX International Conference on Nucleus-Nucleus Collisions", Rio de Janeiro, Aug 28- Sept 1, 2006; to appear on the proceeding issue in Nuclear Physics

Meta-analysis identifies seven susceptibility loci involved in the atopic March

Eczema often precedes the development of asthma in a disease course called the a 'atopic march'. To unravel the genes underlying this characteristic pattern of allergic disease, we conduct a multi-stage genome-wide association study on infantile eczema followed by childhood asthma in 12 populations including 2,428 cases and 17,034 controls. Here we report two novel loci specific for the combined eczema plus asthma phenotype, which are associated with allergic disease for the first time; rs9357733 located in EFHC1 on chromosome 6p12.3 (OR 1.27; P=2.1 × 10 a'8) and rs993226 between TMTC2 and SLC6A15 on chromosome 12q21.3 (OR 1.58; P=5.3 × 10 a'9). Additional susceptibility loci identified

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems